JP2010508499A5 - - Google Patents

Download PDF

Info

Publication number
JP2010508499A5
JP2010508499A5 JP2009533745A JP2009533745A JP2010508499A5 JP 2010508499 A5 JP2010508499 A5 JP 2010508499A5 JP 2009533745 A JP2009533745 A JP 2009533745A JP 2009533745 A JP2009533745 A JP 2009533745A JP 2010508499 A5 JP2010508499 A5 JP 2010508499A5
Authority
JP
Japan
Prior art keywords
factor
inhibitor
activator
heparin
blood plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009533745A
Other languages
English (en)
Japanese (ja)
Other versions
JP5395669B2 (ja
JP2010508499A (ja
Filing date
Publication date
Priority claimed from EP06123234A external-priority patent/EP1918718A1/de
Application filed filed Critical
Publication of JP2010508499A publication Critical patent/JP2010508499A/ja
Publication of JP2010508499A5 publication Critical patent/JP2010508499A5/ja
Application granted granted Critical
Publication of JP5395669B2 publication Critical patent/JP5395669B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009533745A 2006-10-31 2007-10-27 血液試料中の第ｘａ因子インヒビターの電気化学測定のための方法および装置 Active JP5395669B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06123234.4 2006-10-31
EP06123234A EP1918718A1 (de) 2006-10-31 2006-10-31 Verfahren und Vorrichtungen zur elektrochemischen Bestimmung von Faktor Xa-Inhibitoren in Blutproben
PCT/EP2007/009347 WO2008052718A1 (de) 2006-10-31 2007-10-27 Verfahren und vorrichtungen zur elektrochemischen bestimmung von faktor xa-inhibitoren in blutproben

Publications (3)

Publication Number Publication Date
JP2010508499A JP2010508499A (ja) 2010-03-18
JP2010508499A5 true JP2010508499A5 (enExample) 2010-08-05
JP5395669B2 JP5395669B2 (ja) 2014-01-22

Family

ID=37633621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009533745A Active JP5395669B2 (ja) 2006-10-31 2007-10-27 血液試料中の第ｘａ因子インヒビターの電気化学測定のための方法および装置

Country Status (7)

Country Link
US (2) US8636894B2 (enExample)
EP (2) EP1918718A1 (enExample)
JP (1) JP5395669B2 (enExample)
CN (1) CN101535498B (enExample)
CA (1) CA2667957C (enExample)
ES (1) ES2444011T3 (enExample)
WO (1) WO2008052718A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2471945A1 (de) * 2010-12-30 2012-07-04 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Bestimmung von Inhibitoren der Gerinnung
JP5946139B2 (ja) * 2011-03-16 2016-07-05 学校法人 芝浦工業大学 抗凝固薬測定用センサ
EP2818871A1 (en) 2013-06-28 2014-12-31 Roche Diagniostics GmbH Means and methods for universal calibration of anti-Factor Xa tests
EP3198270A1 (en) 2014-09-26 2017-08-02 Abbott Point Of Care, Inc. Cartridge device with fluidic junctions for coagulation assays in fluid samples
EP3198272B1 (en) 2014-09-26 2022-04-06 Abbott Point Of Care, Inc. Cartridge device identification for coagulation assays in fluid samples
US9921232B2 (en) 2014-09-26 2018-03-20 Abbott Point Of Care Inc. Ellagic acid formulations for use in coagulation assays
US10114031B2 (en) 2014-09-26 2018-10-30 Abbott Point Of Care Inc. Single channel cartridge device for coagulation assays in fluid samples
CN107110874B (zh) 2014-09-26 2019-06-04 雅培医护站股份有限公司 用于测定流体样品中的凝固的传感器
EP3197602B1 (en) 2014-09-26 2021-09-01 Abbott Point Of Care, Inc. Microfabricated device with micro-environment sensors for assaying coagulation in fluid samples
US10048281B2 (en) 2014-09-26 2018-08-14 Abbott Point Of Care Inc. Cartridge device with segmented fluidics for assaying coagulation in fluid samples
CN104714036B (zh) * 2015-04-01 2016-06-01 成都协和生物技术有限责任公司 抗凝血酶iii活性测定试剂盒的制备方法
CN105203479A (zh) * 2015-09-21 2015-12-30 山东万邦赛诺康生化制药股份有限公司 用血凝仪测定肝素或低分子量肝素效价的方法
JP7009998B2 (ja) * 2016-01-29 2022-01-26 ソニーグループ株式会社 血液凝固系解析装置、血液凝固系解析システム、血液凝固系解析方法及び血液凝固系解析装置用パラメーターの決定方法
WO2018071982A1 (en) * 2016-10-20 2018-04-26 Universal Biosensors Pty Ltd Non-biohazardous solutions and methods for testing analysers
US12073926B2 (en) 2020-09-21 2024-08-27 Instrumentation Laboratory Company Detecting and monitoring oral anticoagulants or intravenous direct thrombin inhibitors in a blood sample
CN115032164B (zh) * 2022-08-10 2022-12-06 山东省食品药品检验研究院 一种肝素钠中是否含有凝血因子Xa直接抑制剂的检测方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68912477T3 (de) * 1988-03-03 1999-12-23 Nippon Shoji K.K., Osaka Verfahren zum messen der biologischen wirkung von antithrombin iii und reagenzkit zu dessen messung
ATE121139T1 (de) * 1990-11-05 1995-04-15 Baxter Diagnostics Inc Verfahren zur bestimmung der konzentration von antikoagulantien.
US5308756A (en) * 1991-11-20 1994-05-03 Baxter Diagnostics Inc. Protein S chromogenic assay
EP0738389A1 (en) * 1992-09-04 1996-10-23 Gradipore Limited Apparatus and method for detecting coagulation/lysis of liquids
KR100305306B1 (ko) * 1993-02-17 2001-11-22 존 펑크하우저 건식화학캐스케이드면역분석법및친화도분석법
US5762770A (en) * 1994-02-21 1998-06-09 Boehringer Mannheim Corporation Electrochemical biosensor test strip
DK0758341T3 (da) * 1994-04-26 2004-06-28 Aventis Pharma Inc Faktor Xa-inhibitorer
NL1006429C2 (nl) * 1997-06-27 1998-12-29 Univ Maastricht Werkwijze voor het bepalen van het heparinegehalte.
US5997817A (en) * 1997-12-05 1999-12-07 Roche Diagnostics Corporation Electrochemical biosensor test strip
WO2000077246A2 (en) * 1999-06-14 2000-12-21 Novo Nordisk A/S A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
AU2431800A (en) * 1999-12-15 2001-06-25 Pentapharm Ag Hematological assay and reagent
US6438498B1 (en) * 2000-02-10 2002-08-20 I-Stat Corporation System, method and computer implemented process for assaying coagulation in fluid samples
ATE278186T1 (de) * 2000-02-21 2004-10-15 Hoffmann La Roche Elektrochemischer sensor zur bestimmung der blutgerinnung, ein entsprechendes blutgerinnungsmesssystem sowie ein verfahren zur bestimmung der blutgerinnung
US20030146113A1 (en) * 2000-02-21 2003-08-07 Volker Unkrig Electrochemical sensor for determining blood clotting, corresponding system for measuring blood clotting and method for determining blood clotting
US7166208B2 (en) * 2004-03-03 2007-01-23 Stephen Eliot Zweig Apoenzyme reactivation electrochemical detection method and assay
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor
US7579000B2 (en) * 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
EP1682863B1 (en) * 2003-09-22 2012-07-04 University Of North Carolina At Chapel Hill Soluble phospholipids for use in clotting factor assays

Similar Documents

Publication Publication Date Title
JP2010508499A5 (enExample)
JP2008056926A5 (enExample)
JP2010514554A5 (enExample)
JP2007525551A5 (enExample)
TR200900200T2 (tr) Pıhtılaşmayı önleyici özelliklere sahip kalıcı kateter
BRPI0514630A (pt) alfa-mercaptoacetanilidas e s-triazolila como inibidores de transcriptase reversa de hiv
JP2005529870A5 (enExample)
JP2010501670A5 (enExample)
WO2008124682A3 (en) Oxygen-scavenging materials and articles formed therefrom
EP1840287A3 (en) Sound-absorbing panel of porous material and production method of the same
EP2205074A4 (en) MOENOMYCIN ANALOGUE, SYNTHESIS PROCESS AND USE
CL2008000913A1 (es) Consola de control que comprende un cuerpo con una cantidad de controles, una base con un primer y segundo extremos y una primera y segunda secciones, un primer y segundo miembros conectados pivotalmente en un extremo al cuerpo y en el otro extremo a
JP2012136388A5 (enExample)
PL377864A1 (pl) Pochodne 1-N-(fenylo)-2-N-(fenylo)pirazolidyno-1,2-dikarboksyamidowe jako inhibitory czynnika koagulacyjnego Xa do leczenia zakrzepic
DE502005011033D1 (de) Röntgeneinrichtung, insbesondere mammographie-röntgeneinrichtung, mit indikatormitteln in form von leds
FR2900734B1 (fr) Detection des maladies veineuses thromboemboliques par le dosage des d-dimeres et de la fibrine soluble
HRP20180756T1 (hr) Poliesterski polimeri s niskim brzinama stvaranja acetaldehida i visokom koncentracijom vinilnih krajeva
JP2013501511A5 (enExample)
JP2008523232A5 (enExample)
JP2007126453A5 (enExample)
DE502005007034D1 (de) Medizinisches schneid und/oder halteinstrument
JP2005145934A5 (enExample)
EP2016197A4 (en) GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY DISEASE, DETECTION METHODS AND JOBS
WO2006066778A3 (en) Novel heteroarylacetamides
Sadushi-Kolici et al. Plasma Levels Of Soluble P-Selectin Predict Survival In Chronic Thromboembolic Pulmonary Hypertension